Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/17435889.2025.2476377 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Preparation of capecitabine-poly(p-dioxanone) electrospraying nanoparticles and influence of particle size on their colorectal cancer inhibitive efficiency.
J Biomater Appl
March 2025
Department of Chemistry, School of Pharmacy, North Sichuan Medical College, Nanchong, China.
Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. Capecitabine is a chemotherapeutic agent commonly used for the treatment of colon cancer. To realize local sustained release, promote efficient local intracellular transport, and mitigate the systemic toxic effects of capecitabine, a capecitabine prodrug, capecitabine-poly (p-dioxanone) (Cap-PPDO), was successfully synthesized.
View Article and Find Full Text PDFInterfacial-Design Mediated Construction of Hybrid Multicompartment Architectures with Layered Physicochemical Barriers for Separately Sequestration of Oxidation-Reduction Molecules and Their Redox Reaction Regulation.
Small
March 2025
College of Food Science, Southwest University, Chongqing, 400715, China.
Hybrid multicompartment artificial architectures, inherited from different compartmental systems, possess separate microenvironments that can perform different functions. Herein, a hybrid compartmentalized architecture via hybridizing ferritin nanocage (Fn) with non-aqueous droplets using aminated-modified amphiphilic gelatin (AGEL) is proposed, which enables the generation of compartmentalized emulsions with hybrid multicompartments. The resulting compartmentalized emulsions are termed "hybrasome".
View Article and Find Full Text PDFEnhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia-Reperfusion Injury.
Nanomaterials (Basel)
February 2025
School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Acute myocardial infarction, a leading cause of death globally, is often associated with cardiometabolic disorders such as atherosclerosis and metabolic syndrome. Metabolic treatment of these disorders can improve cardiac outcomes, as exemplified by the GLP-1 agonist semaglutide. Fibroblast growth factor 21 (FGF21), a novel metabolic regulator, plays pivotal roles in lipid mobilization and energy conversion, reducing lipotoxicity, inflammation, mitochondrial health, and subsequent tissue damage in organs such as the liver, pancreas, and heart.
View Article and Find Full Text PDFFeCo: Hysteresis, Pseudo-Critical, and Compensation Temperatures on Quasi-Spherical Nanoparticle.
Nanomaterials (Basel)
February 2025
Facultad de Ciencias Básicas, Departamento de Física y Electrónica, Universidad de Córdoba, Monteria 230002, Colombia.
We investigated the hysteresis, pseudo-critical, and compensation behaviors of a quasi-spherical FeCo alloy nanoparticle (2 nm in diameter) using Monte Carlo simulations with thermal bath-type algorithms and a 3D mixed Ising model. The nanostructure was modeled in a body-centered cubic lattice (BCC) through the following configurations: spin S=3/2 for Co and Q=2 for Fe. These simulations reveal that, under the influence of crystal and magnetic fields, the nanoparticle exhibits compensation phenomena, exchange bias, and pseudo-critical temperatures.
View Article and Find Full Text PDFDocetaxel-loaded, dipeptide-functionalized γ-Fe2O3 magnetic nanoparticles: Synthesis, characterization and targeting to prostate cancer.
Chem Biodivers
March 2025
Dicle University: Dicle Universitesi, Faculty of Science, Diyarbakır, Diyarbakır, TURKEY.
A new delivery system was designed and synthesized to increase the efficiency of Docetaxel. For this aim, γ-Fe2O3 was synthesized in order to give the nanoparticle the ability to be magnetic targeted. It was functionalized with citric acid to prevent clumping and maintain stability.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!